Lilly suspends investments in Russia amid Ukraine crisis

Eli Lilly and Company has suspended all investments and promotional works in Russia and will only deliver medicines for urgent medical ailments such as cancer and diabetes amid the Ukraine crisis.

The company also halted new clinical trials and the exporting of non-essential medicines to Russia.

On generating profits from the continued sales of essential drugs in Russia, Lilly intends to donate them to the organisations that provide humanitarian relief

In a statement, the company said: “Our Russian operations are now only focused on ensuring people suffering from diseases like cancer and diabetes continue to get the Lilly medicines they need.

“We have an ethical and moral obligation to help alleviate human suffering and to protect the lives of patients

Apart from the donations of lifesaving therapies, the tax-exempt organisation of the company Lilly Foundation is extending contributions worth $500,000.

The Lilly Foundation is also providing a $500,000 donation in two equal parts to Direct Relief and Americares to aid in their respective relief operations in Ukraine.

Furthermore, Lilly is contributing insulin worth $7.5m to a US non-profit organisation (NGO) called Project HOPE that aids healthcare professionals to tackle the world’s greatest health crises

At present, the NGO is operating in Ukraine and neighbouring nations, actively providing essential drugs and medical supplies for the people of Ukraine

Be the first to comment

Leave a Reply

Your email address will not be published.


*